Developments Formycon, MS partner to commercialize Keytruda biosimilar candidate in MENA region Formycon AG (FSE: FYB, Prime Standard) and closely held MS Pharma have jointly announced that they have entered into an exclusive licensing and supply agreement for the commercialization of FYB206—Formycon’s biosimilar... December 9, 2025